drugset / Trial / NCT03940950

Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee

NCT03940950

Phase 1 Completed 9 enrolled Mayo Clinic
RandomizedParallel-groupSingle-blindTreatment

Summary

Researchers are trying to determine the safety and feasibility of autologous, adipose derived stromal vascular fraction injections in the treatment of knee osteoarthritis

Timeline

Start
2019-07-02
Primary completion
2025-05-05
Completion
2025-05-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy Other

Indications